Alemtuzumab Induction with Rapid Corticosteroid Elimination Is Associated with Comparable Outcomes in High Immunologic Risk and Non High Risk Renal Transplant Recipients

被引：0

作者：

Hibbs, Jennifer ^{[1
]}

Hamdallah, Omar ^{[1
]}

Cannon, Robert ^{[1
]}

Ravindra, Kadiyala ^{[1
]}

Ouseph, Rosemary ^{[1
]}

Gleason, John ^{[1
]}

Woo, Dan ^{[1
]}

Attallah, N. ^{[1
]}

Carpenter, Lisa ^{[1
]}

Mattingly, Carol ^{[1
]}

Padgett, Kay ^{[1
]}

Tingle, Beth ^{[1
]}

Bellis, Nancy ^{[1
]}

Oliver, Lori ^{[1
]}

Bilinski, Kristen ^{[1
]}

Steele, Misty ^{[1
]}

Luger, Alan ^{[1
]}

Brock, Guy ^{[1
]}

Marvin, Michael ^{[1
]}

Meyers, John ^{[1
]}

Eng, Mary ^{[1
]}

Buell, Joseph ^{[1
]}

机构：

[1] Univ Louisville, Div Transplantat, Jewish Transplant Ctr, Louisville, KY 40292 USA

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：322 / 322

页数：1

共 50 条

[1] Renal Transplantation in Immunologic High Risk Recipients
Salas, P.
Pinto, V.
Zambrano, P.
Grandy, J.
Corta, B.
PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1897 - 1897
[2] A Comparison of Alemtuzumab and Antithymocyte Globulin Induction in High-Risk, Non-Sensitized African American Renal Transplant Recipients
Janusek, M.
Patel, S.
Galen, K.
West-Thilke, P.
Benedetti, E.
Thielke, J.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[3] A Comparison of Alemtuzumab versus Antithymocyte Globulin Induction in High-Risk, Non-Sensitized Renal Transplant Recipients.
Patel, S.
Lichvar, A.
Benedetti, E.
West-Thielke, P.
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 676 - 677
[4] Patient and Graft Outcome among High Immunologic Risk Renal Transplant Recipients
Mora, Jeffrey
Cabanayan-Casasola, Concesa B.
Padua, Florecita R.
Mendoza, Myrna T.
TRANSPLANTATION, 2018, 102 : S485 - S486
[5] Patient and Graft Outcome Among High Immunologic Risk Renal Transplant Recipients
Mora, Jeffrey
Cabanayan-Casasola, Concesa B.
Padua, Florecita R.
Mendoza, Myrna T.
TRANSPLANTATION, 2018, 102 : S90 - S91
[6] Cytomegalovirus Prophylaxis Following Alemtuzumab Induction in High Risk Renal Transplant Recipients Experiencing Delayed Graft Function.
Freedman, S.
Ravichandran, B.
Masters, B.
Heil, E.
Saharia, K.
Bromberg, J.
Haririan, A.
Sparkes, T.
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 671 - 672
[7] Thymoglobulin Versus Alemtuzumab Induction in High Immunologic Risk Kidney Transplants.
Lockridge, J.
Pryor, J.
Norman, D.
Olyaei, A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 819 - 819
[8] Rejection and Infection Risk After Basiliximab Induction in Low Immunologic-Risk Kidney Transplant Recipients at a High Volume Transplant Center
Danobeitia, J. S.
Leverson, G.
Welch, B.
Stalter, L.
Swanson, K.
Hellner, J.
Smith, J.
Parajuli, S.
Mandelbrot, D.
Wang, J. Garonzik
AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S835 - S836
[9] Alemtuzumab Induction Is Associated With Higher Risk of Polyomavirrus Associated Nephropathy (PVAN) in Kidney Transplant Recipients
Wadei, H.
Saull, H.
Enderby, C.
Mai, M.
Prendergast, M.
Gonwa, T.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[10] Outcomes of Low Immunologic Risk Kidney Transplant Recipients (KTRs) Receiving Depletional Induction
Khamash, Hasan
Hanaway, Michael
Mannon, Roslyn
Kumar, Vineeta
Julian, Bruce
Cook, William
Gaston, Robert
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 321 - 321

← 1 2 3 4 5 →